Claims for Patent: 10,213,546

✉ Email this page to a colleague

Summary for Patent: 10,213,546

Title:	Devices and methods for delivering a beneficial agent to a user
Abstract:	A device for delivering a beneficial agent is provided and generally includes a cassette, a pump, and a delivery tube. The pump includes a pump housing containing a pump assembly having a fluid drive component. The pump housing has a receiving region disposed proximate the fluid drive component and further includes a rear closure portion. The rear closure portion includes a membrane disposed between the receiving region and the fluid drive component. The cassette includes a cassette housing, which has a cassette body region defining a fluid reservoir chamber therein. The cassette further includes a cassette base region having a boundary configured to be received by the receiving region.
Inventor(s):	Phil Anderson, Kevin Novak, Kevin Mclennan, Michael Mackaplow, Guiyong Song, Gurjinder Singh Dhami, Benjamin Alan Jasperson, Scott Smieja, Matthew Svacina
Assignee:	AbbVie Inc
Application Number:	US15/064,481

Details for Patent 10,213,546

Glossary

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	⤷ Get Started Free	2036-03-08
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	November 21, 2018	⤷ Get Started Free	2036-03-08
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,213,546

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2015103385	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2015103382	⤷ Get Started Free
United States of America	2025170326	⤷ Get Started Free
United States of America	2024139409	⤷ Get Started Free
United States of America	2022379011	⤷ Get Started Free
United States of America	2019134299	⤷ Get Started Free
United States of America	2016184507	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.